Company Filing History:
Years Active: 2024
Title: Vahid Hamzeinejad: Innovator in Arteriogenesis Enhancement
Introduction
Vahid Hamzeinejad is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical science, particularly in enhancing arteriogenesis. His innovative methods aim to improve blood flow in patients suffering from ischemic diseases.
Latest Patents
Hamzeinejad holds a patent for "Methods and compositions to enhance arteriogenesis." This patent describes a method for enhancing arteriogenesis in animals with comorbidities commonly found in patients with ischemic disease. The method involves administering satellite-derived myoblasts to increase the maximum diameter of collateral arteries. This approach is particularly effective in obese animals or those with genetically impaired arteriogenesis responses. The administration of myoblasts to non-obese animals does not yield the same results. The patent highlights the potential for increased blood flow and decreased ischemia, along with compositions and kits comprising the myoblasts.
Career Highlights
Vahid Hamzeinejad is associated with Cal Poly Corporation, where he continues to work on innovative solutions in the medical field. His research focuses on improving the quality of life for patients with vascular issues.
Collaborations
Hamzeinejad collaborates with talented individuals such as Trevor Cardinal and Ethan Tietze, contributing to advancements in his field.
Conclusion
Vahid Hamzeinejad's work in enhancing arteriogenesis represents a significant step forward in medical innovation. His patented methods and ongoing research have the potential to greatly benefit patients with ischemic diseases.